George Abercrombie

(Mr. George Abercrombie)

Currently holds positions in Brickell Biotech Inc and BioCryst Pharmaceuticals Inc

Positions

Position Company Period
Director Brickell Biotech Inc Aug. 31, 2019 -
Independent Director BioCryst Pharmaceuticals Inc May 24, 2017 -
Senior Vice President, Chief Commercial Officer Innoviva Inc April 20, 2016 - Sept. 26, 2018
Non-Executive Independent Chairman of the Board BioCryst Pharmaceuticals Inc May 1, 2013 - May 24, 2017
Senior Vice President - Corporate Partnerships, Commercial Innoviva Inc June 12, 2014 - April 20, 2016
Independent Director Ocera Therapeutics Inc Sept. 19, 2011 - July 15, 2013
Independent Director BioCryst Pharmaceuticals Inc Oct. 10, 2011 - May 1, 2013
George Abercrombie's trades of BioCryst Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-04-20 2022-04-18 PS Planned sale
5,000 -100.0%
11.04
USD 55,200
5,000 -100.0% 11.04 USD 55,200
2022-02-16 2022-02-15 PS Planned sale
5,000 -100.0%
18.50
USD 92,500
5,000 -100.0% 18.50 USD 92,500
2021-11-17 2021-11-15 PS Planned sale
5,000 -100.0%
12.27
USD 61,350
5,000 -100.0% 12.27 USD 61,350
2021-09-17 2021-09-15 PS Planned sale
5,000 -100.0%
15.06
USD 75,300
5,000 -100.0% 15.06 USD 75,300
2021-09-14 2021-09-10 S Sale
74,000 -100.0%
15.09
USD 1,116,660
74,000 -100.0% 15.09 USD 1,116,660
2021-05-26 2021-05-24 PS Planned sale
6,667 -69.0%
13.90
USD 92,671
6,667 -69.0% 13.90 USD 92,671
// ... existing code ... // ... rest of the file ...